Weill Cornell Medicine has received a $1.4 million, four-year grant from the U.S. Department of Defense to investigate a new therapeutic approach for the most common form of kidney cancer.
Weill Cornell Medicine has received a $1.4 million, four-year grant from the U.S. Department of Defense to investigate a new therapeutic approach for the most common form of kidney cancer.
New research findings indicate that exposure to even low levels of arsenic poses significant health risks, including an increased risk of kidney cancer.
Some results have been hidden because they may be inaccessible to you